Adenoma Sebaceum – Causes, Symptoms and Treatment
Adenoma sebaceum refers to benign skin lesions on the face, typically associated with tuberous sclerosis. Despite the name, they are facial angiofibromas, not true adenomas.
Things worth knowing about "Adenoma Sebaceum"
Adenoma sebaceum refers to benign skin lesions on the face, typically associated with tuberous sclerosis. Despite the name, they are facial angiofibromas, not true adenomas.
What is Adenoma Sebaceum?
Adenoma sebaceum is a historically rooted term for benign skin lesions that appear primarily on the face. Despite its name, this condition does not involve true adenomas (glandular tumors) of the sebaceous glands. Instead, the lesions are facial angiofibromas -- benign overgrowths of blood vessels and connective tissue within the skin. The term is today used almost exclusively in the clinical context of tuberous sclerosis complex (Bourneville-Pringle disease).
Causes and Association with Tuberous Sclerosis
Adenoma sebaceum occurs almost exclusively as a feature of tuberous sclerosis complex (TSC), a rare genetic disorder caused by mutations in the TSC1 gene (chromosome 9) or the TSC2 gene (chromosome 16). These genes encode the proteins hamartin and tuberin, which together function as tumor suppressors. Loss of function leads to uncontrolled cell proliferation and the formation of hamartomas in multiple organs, including the skin.
- Autosomal dominant inheritance or spontaneous new mutation
- Prevalence of tuberous sclerosis: approximately 1 in 6,000 to 1 in 10,000 individuals
- Adenoma sebaceum is present in approximately 75 to 90 percent of affected individuals
Symptoms and Clinical Appearance
The skin lesions typically appear during early childhood, between the ages of 2 and 5, and tend to increase in number and size around puberty. They present as:
- Small, reddish-brown or skin-colored papules (raised skin nodules)
- Symmetrical distribution in the nasolabial area (cheeks, nose, chin)
- Smooth, shiny surface
- Butterfly-shaped pattern across the nose and cheeks
- Generally painless but cosmetically distressing
Other skin signs of tuberous sclerosis include shagreen patches (connective tissue plaques on the back), hypopigmented macules (ash-leaf spots), and periungual fibromas (fibromas around the nails).
Diagnosis
Diagnosis is primarily clinical, based on the characteristic appearance and the association with other features of tuberous sclerosis. The following approaches are used for confirmation:
- Skin biopsy: Histology reveals dilated blood vessels and fibrous connective tissue consistent with angiofibroma
- Genetic testing: Identification of pathogenic variants in TSC1 or TSC2
- Imaging: Brain MRI, renal ultrasound, and echocardiography to evaluate systemic involvement
- Wood lamp examination: Highlights hypopigmented skin macules
The diagnosis of tuberous sclerosis is based on the consensus criteria established at the 2012 International Tuberous Sclerosis Complex Consensus Conference.
Treatment
Adenoma sebaceum is benign and does not require medically necessary treatment. However, due to significant cosmetic impact, several treatment options are available:
Laser Treatment
Laser ablation -- including CO2 laser, Nd:YAG laser, or pulsed dye laser -- is considered the treatment of choice. It allows gentle removal of angiofibromas with good cosmetic outcomes, though recurrence is common.
Topical mTOR Inhibitors
In recent years, topical application of sirolimus (rapamycin) cream has become available. Since tuberous sclerosis results from overactivation of the mTOR signaling pathway, local inhibition of this pathway can halt or reverse the growth of angiofibromas. Clinical studies have demonstrated significant improvement in skin lesions.
Systemic Therapy
For severe systemic manifestations of tuberous sclerosis (such as renal angiomyolipomas or subependymal giant cell astrocytomas), systemic mTOR inhibitors such as everolimus or sirolimus are used.
Other Procedures
- Dermabrasion
- Cryotherapy (cold therapy)
- Surgical excision for individual, larger lesions
Prognosis
Adenoma sebaceum itself is benign and not life-threatening. The overall prognosis of tuberous sclerosis depends on the severity of systemic involvement, particularly neurological manifestations such as epilepsy and cognitive impairment, as well as renal complications.
References
- Northrup H, Krueger DA; International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatric Neurology. 2013;49(4):243-254.
- Wataya-Kaneda M et al. Clinical and histologic analysis of the efficacy of topical rapamycin therapy against facial angiofibromas in the tuberous sclerosis complex. JAMA Dermatology. 2012;148(1):39-48.
- Schwartz RA, Fernandez G, Kotulska K, Jozwiak S. Tuberous sclerosis complex: advances in diagnosis, genetics, and management. Journal of the American Academy of Dermatology. 2007;57(2):189-202.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryCalorie deficit
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Adenoma Sebaceum-en